Rezolute, Inc.RZLTNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank51
3Y CAGR-39.9%
5Y CAGR-37.0%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-39.9%/yr
vs -20.4%/yr prior
5Y CAGR
-37.0%/yr
Consistent
Acceleration
-19.6pp
Decelerating
Percentile
P51
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 9.12% |
| Q3 2025 | -36.97% |
| Q2 2025 | 36.51% |
| Q1 2025 | 21.03% |
| Q4 2024 | -1.00% |
| Q3 2024 | -33.19% |
| Q2 2024 | 53.93% |
| Q1 2024 | 3.01% |
| Q4 2023 | -1.43% |
| Q3 2023 | 11.72% |
| Q2 2023 | -23.17% |
| Q1 2023 | 30.02% |
| Q4 2022 | 42.07% |
| Q3 2022 | -10.15% |
| Q2 2022 | -1.29% |
| Q1 2022 | -8.10% |
| Q4 2021 | 63.70% |
| Q3 2021 | 31.56% |
| Q2 2021 | 16.79% |
| Q1 2021 | -16.41% |
| Q4 2020 | 91.81% |
| Q3 2020 | -4.13% |
| Q2 2020 | -34.50% |
| Q1 2020 | -25.90% |
| Q4 2019 | 55.78% |
| Q3 2019 | 88.22% |
| Q2 2019 | -88.64% |
| Q1 2019 | 1055.13% |
| Q4 2018 | 40.78% |
| Q3 2018 | -86.83% |
| Q2 2018 | 182.82% |
| Q1 2018 | -26.86% |
| Q4 2017 | -20.82% |
| Q3 2017 | 39.31% |
| Q2 2017 | -10.02% |
| Q1 2017 | 11.83% |
| Q4 2016 | 23.71% |
| Q3 2016 | -6.05% |
| Q2 2016 | 14.54% |
| Q1 2016 | -8.47% |